A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months
Clinical trial NCT07282171 · RECRUITING
Trial details
- NCT number
- NCT07282171
- Sponsor
- Comanche Biopharma
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-26
- Primary completion
- 2027-03-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.